BATS BZX Real-Time Price
As of 11:24am ET
| +0.09 / +0.13%|
The 27 analysts offering 12-month price forecasts for Novartis have a median target of 80.66, with a high estimate of 92.00 and a low estimate of 68.03. The median estimate represents a +14.38% increase from the last price of 70.52.
The current consensus among 29 polled investment analysts is to Hold stock in Novartis. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.